secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autonomix Medical, Inc. (AMIX)
CIK:        0001617867
Form:       8-K
Filed at:   2025-02-28T23:59:59+00:00
Accession:  0001437749-25-005739
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autonomix Medical enters $2.1M ATM equity facility; reverse split share dispute
-------------------------------------------------------------------------------

- Entered ATM sales agreement with Ladenburg Thalmann for up to $2.1M of common stock; 3.0% agent commission.
- Proceeds from ATM to be used for working capital and general corporate purposes.
- October 2024 1-for-20 reverse split reduced shares from ~23M to ~1.15M; authorized shares remain 500M.
- DTCC requested 271,846 shares for fractional rounding; company disputes and has not issued; potential liability.
- Retrospective restatement of per-share data in 10-K to reflect reverse split; no new financial results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617867/000143774925005739/0001437749-25-005739-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617867/000143774925005739/amix20250224_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-005739

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer